Latest Cormorant Asset Management, LP Stock Portfolio
Cormorant Asset Management, LP Performance:
2024 Q3: 10%YTD: 5.92%2023: 29.65%
Performance for 2024 Q3 is 10%, and YTD is 5.92%, and 2023 is 29.65%.
About Cormorant Asset Management, LP and 13F Hedge Fund Stock Holdings
Cormorant Asset Management, LP is a hedge fund based in BOSTON, MA. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $3.1 Billions. In it's latest 13F Holdings report, Cormorant Asset Management, LP reported an equity portfolio of $1.9 Billions as of 30 Sep, 2024.
The top stock holdings of Cormorant Asset Management, LP are MLTX, PCVX, ACLX. The fund has invested 22.7% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.1% of portfolio in VAXCYTE INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), CULLINAN THERAPEUTICS INC (CGEM) and IDEAYA BIOSCIENCES INC (IDYA) stocks. They significantly reduced their stock positions in BIOHAVEN LTD, INSMED INC (INSM) and CRINETICS PHARMACEUTICALS IN (CRNX). Cormorant Asset Management, LP opened new stock positions in BIOAGE LABS INC and ANAPTYSBIO INC (ANAB). The fund showed a lot of confidence in some stocks as they added substantially to AVIDITY BIOSCIENCES INC (RNA), CENTESSA PHARMACEUTICALS PLC (CNTA) and PRAXIS PRECISION MEDICINES I (PRAX).
The top stock holdings of Cormorant Asset Management, LP are MLTX, PCVX, ACLX. The fund has invested 22.7% of it's portfolio in MOONLAKE IMMUNOTHERAPEUTICS and 6.1% of portfolio in VAXCYTE INC.
The fund managers got completely rid off SAREPTA THERAPEUTICS INC (SRPT), CULLINAN THERAPEUTICS INC (CGEM) and IDEAYA BIOSCIENCES INC (IDYA) stocks. They significantly reduced their stock positions in BIOHAVEN LTD, INSMED INC (INSM) and CRINETICS PHARMACEUTICALS IN (CRNX). Cormorant Asset Management, LP opened new stock positions in BIOAGE LABS INC and ANAPTYSBIO INC (ANAB). The fund showed a lot of confidence in some stocks as they added substantially to AVIDITY BIOSCIENCES INC (RNA), CENTESSA PHARMACEUTICALS PLC (CNTA) and PRAXIS PRECISION MEDICINES I (PRAX).
Cormorant Asset Management, LP Annual Return Estimates Vs S&P 500
Our best estimate is that Cormorant Asset Management, LP made a return of 10% in the last quarter. In trailing 12 months, it's portfolio return was 32.94%.
New Buys
| Ticker | $ Bought |
|---|---|
| bioage labs inc | 33,894,200 |
| mbx biosciences inc | 18,186,000 |
| anaptysbio inc | 11,472,600 |
| artiva biotherapeutics inc | 1,601,130 |
New stocks bought by Cormorant Asset Management, LP
Additions
| Ticker | % Inc. |
|---|---|
| avidity biosciences inc | 147 |
| centessa pharmaceuticals plc | 58.95 |
| praxis precision medicines i | 27.01 |
| corbus pharmaceuticals hldgs | 17.28 |
| arrivent biopharma inc | 13.68 |
| edgewise therapeutics inc | 13.3 |
| newamsterdam pharma company | 7.39 |
| rapport therapeutics inc | 0.02 |
Additions to existing portfolio by Cormorant Asset Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| biohaven ltd | -49.88 |
| silence therapeutics plc | -36.00 |
| insmed inc | -25.93 |
| crinetics pharmaceuticals in | -18.52 |
| arcellx inc | -18.03 |
| rhythm pharmaceuticals inc | -15.79 |
| merus n v | -11.9 |
| vaxcyte inc | -9.09 |
Cormorant Asset Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| mersana therapeutics inc | -5,226,000 |
| compass therapeutics inc | -2,030,820 |
| cullinan therapeutics inc | -19,620,000 |
| ideaya biosciences inc | -8,601,950 |
| sarepta therapeutics inc | -19,750,000 |
| lantheus hldgs inc | -6,021,750 |
Cormorant Asset Management, LP got rid off the above stocks
Sector Distribution
Cormorant Asset Management, LP has about 81.8% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.8 |
| Others | 18.2 |
Market Cap. Distribution
Cormorant Asset Management, LP has about 1.9% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 49.9 |
| SMALL-CAP | 25.8 |
| UNALLOCATED | 20.3 |
| MICRO-CAP | 2 |
| LARGE-CAP | 1.9 |
Stocks belong to which Index?
About 47.4% of the stocks held by Cormorant Asset Management, LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 52.6 |
| RUSSELL 2000 | 47.4 |
Cormorant Asset Management, LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Cormorant Asset Management, LP
Cormorant Asset Management, LP has 45 stocks in it's portfolio. About 59% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. MLTX was the most profitable stock for Cormorant Asset Management, LP last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACLX | arcellx inc | 5.54 | 1,250,000 | 104,388,000 | reduced | -18.03 | ||
| ANAB | anaptysbio inc | 0.61 | 342,465 | 11,472,600 | new | |||
| ARQT | arcutis biotherapeutics inc | 1.15 | 2,325,000 | 21,622,500 | reduced | -7.92 | ||
| AXSM | axsome therapeutics inc | 1.91 | 400,000 | 35,948,000 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc | 2.51 | 1,858,350 | 47,313,600 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc | 1.91 | 3,570,870 | 36,065,800 | unchanged | 0.00 | ||
| CGEM | cullinan therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CMPX | compass therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTA | centessa pharmaceuticals plc | 2.17 | 2,561,600 | 40,960,000 | added | 58.95 | ||
| CRBP | corbus pharmaceuticals hldgs | 2.60 | 2,375,000 | 48,996,200 | added | 17.28 | ||
| CRNX | crinetics pharmaceuticals in | 2.98 | 1,100,000 | 56,210,000 | reduced | -18.52 | ||
| EWTX | edgewise therapeutics inc | 4.82 | 3,406,530 | 90,920,400 | added | 13.3 | ||
| EYPT | eyepoint pharmaceuticals inc | 3.53 | 8,325,000 | 66,516,800 | unchanged | 0.00 | ||
| IDYA | ideaya biosciences inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| INSM | insmed inc | 1.94 | 500,000 | 36,500,000 | reduced | -25.93 | ||
| JANX | janux therapeutics inc | 2.53 | 1,050,000 | 47,701,500 | unchanged | 0.00 | ||
| LBPH | longboard pharmaceuticals in | 4.93 | 2,790,460 | 93,006,100 | unchanged | 0.00 | ||
| LNTH | lantheus hldgs inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| MLTX | moonlake immunotherapeutics | 22.71 | 8,494,150 | 428,275,000 | unchanged | 0.00 | ||
| MRSN | mersana therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||